New eye drug OCU200 tested for diabetes-related vision loss
NCT ID NCT05802329
First seen Dec 16, 2025 · Last updated May 20, 2026 · Updated 19 times
Summary
This early-stage study tests a new drug called OCU200 for people with diabetic macular edema, a condition where fluid builds up in the center of the retina and blurs vision. The main goal is to check safety and side effects, while also measuring how well the drug improves eyesight and reduces swelling. About 24 adults with diabetes and vision loss will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Advanced Research LLC
RECRUITINGDeerfield Beach, Florida, 33064, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Contact
-
Erie Retina Research, LLC
RECRUITINGErie, Pennsylvania, 16507, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Gundersen Health System
RECRUITINGLa Crosse, Wisconsin, 54601, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Retina Consultants of America
RECRUITINGSouthlake, Texas, 76092, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Retina Consultants of Texas Research Centers
RECRUITINGBellaire, Texas, 77401, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.